{"DataElement":{"publicId":"14737354","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset Unacceptable Toxicity Relationship Category","preferredDefinition":"Text term that represents the unacceptable toxicity relatedness category.","longName":"SUPPAE_QVAL_AEUNACPT_TOXREL","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14737349","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset Unacceptable Toxicity Relationship","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.:Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death._A state of connectedness between people, objects, or events; to be associated or connected with something.","longName":"6819753v1.00:14737348v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6819753","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.","longName":"C147185","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Events Supplemental Qualifiers Dataset","conceptCode":"C147185","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DFF23F4-C1A1-5F5B-E053-F662850A7D89","latestVersionIndicator":"Yes","beginDate":"2019-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-18","modifiedBy":"ONEDATA","dateModified":"2019-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14737348","version":"1","preferredName":"Unacceptable Toxicity Relationship","preferredDefinition":"Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death._A state of connectedness between people, objects, or events; to be associated or connected with something.","longName":"C199267:C25648","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unacceptable Toxicity","conceptCode":"C199267","definition":"Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"101D807A-119C-2A92-E063-731AD00A9456","latestVersionIndicator":"Yes","beginDate":"2024-01-29","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-01-29","modifiedBy":"MMADDINENI","dateModified":"2024-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"101D807A-119D-2A92-E063-731AD00A9456","latestVersionIndicator":"Yes","beginDate":"2024-01-29","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-01-29","modifiedBy":"MMADDINENI","dateModified":"2024-01-29","changeDescription":null,"administrativeNotes":"1/29/2024: Created DEC(CADSR0003310)- MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6568712","version":"1","preferredName":"Unacceptable Toxicity Category","preferredDefinition":"Failing to satisfy an established set of qualifying measures._The finding of bodily harm due to the poisonous effects of something._A grouping of items based on some commonality or by user defined characteristics.","longName":"6568712v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"6149013","version":"1","preferredName":"None","longName":"6149013v1.00","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68547E1A-4C9A-6A4E-E053-F662850A8A33","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"NELSONA","dateCreated":"2018-03-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-57C9-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Failure to recover ANC","valueDescription":"Failure to recover ANC to ≥ 750/mm3 by Day 35 of a cycle.","ValueMeaning":{"publicId":"6568713","version":"1","preferredName":"Failure to recover ANC to ≥ 750/mm3 by Day 35 of a cycle.","longName":"6568713","preferredDefinition":"Failure to recover ANC to ≥ 750/mm3 by Day 35 of a cycle","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-57D3-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-57EC-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Neuropathy following 50% dose reduction","valueDescription":"Grade >= 3 neuropathy that recurs following a 50% dose reduction","ValueMeaning":{"publicId":"6568714","version":"1","preferredName":"Grade >= 3 neuropathy that recurs following a 50% dose reduction","longName":"6568714","preferredDefinition":"Grade >= 3 neuropathy that recurs following a 50% dose reduction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-57F6-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-580F-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Grade 4 Neuropathy","valueDescription":"Grade 4 neuropathy that does not resolve to baseline prior to the next cycle of therapy.","ValueMeaning":{"publicId":"6568715","version":"1","preferredName":"Grade 4 neuropathy that does not resolve to baseline prior to the next cycle of therapy.","longName":"6568715","preferredDefinition":"Grade 4 neuropathy that does not resolve to baseline prior to the next cycle of therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-5819-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-5832-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Respiratory toxicity","valueDescription":"Respiratory toxicity requiring ventilator support >= 24 hours, including Grade 4 respiratory toxicity.","ValueMeaning":{"publicId":"6568716","version":"1","preferredName":"Respiratory toxicity requiring ventilator support >= 24 hours, including Grade 4 respiratory toxicity.","longName":"6568716","preferredDefinition":"Respiratory toxicity requiring ventilator support >= 24 hours, including Grade 4 respiratory toxicity.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-583C-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-5855-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":"Hypotension requiring the use of pressors for >= 24 hours, including Grade 4 capillary leak syndrome or Grade 3 and 4 hypotension requiring pressors.","ValueMeaning":{"publicId":"6568717","version":"1","preferredName":"Hypotension requiring the use of pressors for >= 24 hours, including Grade 4 capillary leak syndrome or Grade 3 and 4 hypotension requiring pressors.","longName":"6568717","preferredDefinition":"Hypotension requiring the use of pressors for >= 24 hours, including Grade 4 capillary leak syndrome or Grade 3 and 4 hypotension requiring pressors.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-585F-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B97E72D-5878-04F7-E053-F662850ACE3E","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Toxic Death","valueDescription":"Toxic Death","ValueMeaning":{"publicId":"7414350","version":"1","preferredName":"Toxic Death","longName":"7414350","preferredDefinition":"Toxic Death","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-DFC0-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-DFD9-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Grade 4 diarrhea that persists despite supportive care as detailed in Section 4.2.1 and Appendix V","valueDescription":"Grade 4 diarrhea that persists despite supportive care as detailed in Section 4.2.1 and Appendix V","ValueMeaning":{"publicId":"7414351","version":"1","preferredName":"Grade 4 diarrhea that persists despite supportive care as detailed in Section 4.2.1 and Appendix V","longName":"7414351","preferredDefinition":"Grade 4 diarrhea that persists despite supportive care as detailed in Section 4.2.1 and Appendix V","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-DFE3-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-DFFC-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Grade 4 documented infection (infections and infestations-other, specify)","valueDescription":"Grade 4 documented infection (infections and infestations-other, specify).","ValueMeaning":{"publicId":"7414352","version":"1","preferredName":"Grade 4 documented infection (infections and infestations-other, specify).","longName":"7414352","preferredDefinition":"Grade 4 documented infection [(infections and infestations-other, specify)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E006-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-E01F-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Grade 4 Cytokine Release Syndrome or Acute Infusion Reaction","valueDescription":"Grade 4 Cytokine Release Syndrome or Acute Infusion Reaction","ValueMeaning":{"publicId":"7414353","version":"1","preferredName":"Grade 4 Cytokine Release Syndrome or Acute Infusion Reaction","longName":"7414353","preferredDefinition":"Grade 4 Cytokine Release Syndrome or Acute Infusion Reaction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E029-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-E042-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Peripheral sensory neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","valueDescription":"Peripheral sensory neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","ValueMeaning":{"publicId":"7414354","version":"1","preferredName":"Peripheral sensory neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","longName":"7414354","preferredDefinition":"Peripheral sensory neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E04C-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-E065-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Peripheral motor neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","valueDescription":"Peripheral motor neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","ValueMeaning":{"publicId":"7414355","version":"1","preferredName":"Peripheral motor neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","longName":"7414355","preferredDefinition":"Peripheral motor neuropathy Grade 4 or Grade 3 that does not resolve prior to start of next cycle of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E06F-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEE51443-E088-40EF-E053-4EBD850AD8C2","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","deletedIndicator":"No"},{"value":"Toxicity requiring ventilatory support greater than or equal to 24 hours. (refer to section 9.3.3.2)","valueDescription":"Toxicity With Ventilator Use Greater Than 24 hours","ValueMeaning":{"publicId":"7445937","version":"1","preferredName":"Toxicity With Ventilator Use Greater Than 24 hours","longName":"7445937","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: Used to indicate the presence of something or someone.: A medical device that facilitates breathing.: A manner, or usual, or accepted practice of using something.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: Vo value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Ventilator","conceptCode":"C38388","definition":"A medical device that facilitates breathing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"24 hours","conceptCode":"C0439584","definition":"Vo value exists.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B061BEBE-6918-16BA-E053-4EBD850A927C","latestVersionIndicator":"Yes","beginDate":"2020-09-28","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B061BEBE-6931-16BA-E053-4EBD850A927C","beginDate":"2020-09-28","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"Toxicity requiring the use of pressors for greater than or equal to 24 hours. (refer to section 9.3.3.2)","valueDescription":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","ValueMeaning":{"publicId":"7414356","version":"1","preferredName":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","longName":"7414356","preferredDefinition":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E092-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B061BEBE-6945-16BA-E053-4EBD850A927C","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"Toxicity requiring the use of pressors for greater than or equal to 24 hours.(refer to section 9.3.3.2)","valueDescription":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","ValueMeaning":{"publicId":"7414356","version":"1","preferredName":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","longName":"7414356","preferredDefinition":"Toxicity requiring the use of pressors for greater than or equal to 24 hours, including Grade 4 capillary leak syndrome, Grade 4 anaphylaxis or allergic reaction or Grade 3 or 4 hypotension requiring pressors.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEE51443-E092-40EF-E053-4EBD850AD8C2","latestVersionIndicator":"Yes","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-09","modifiedBy":"ONEDATA","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B06240F5-E0A6-6155-E053-4EBD850AD34E","beginDate":"2020-09-09","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-28","modifiedBy":"ONEDATA","dateModified":"2020-09-28","deletedIndicator":"No"},{"value":"Dinutuximab","valueDescription":null,"ValueMeaning":{"publicId":"3597790","version":"1","preferredName":"Monoclonal Antibody Ch14.18","longName":"3597790","preferredDefinition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Monoclonal antibody Ch14.18 binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dinutuximab","conceptCode":"C1570","definition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CAB1DA52-E763-FF72-E040-BB89AD436B31","latestVersionIndicator":"Yes","beginDate":"2012-09-27","endDate":null,"createdBy":"WONGW","dateCreated":"2012-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"105ACA4E-F99E-04D7-E063-731AD00A67CD","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","deletedIndicator":"No"},{"value":"Protocol therapy","valueDescription":null,"ValueMeaning":{"publicId":"14741316","version":"1","preferredName":"On Protocol Therapy","longName":"14741316v1.00","preferredDefinition":"Subject is receiving treatment based on protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"On Protocol Therapy","conceptCode":"C181023","definition":"Subject is receiving treatment based on protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"105ACA4E-F99D-04D7-E063-731AD00A67CD","latestVersionIndicator":"Yes","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"105ACA4E-F99F-04D7-E063-731AD00A67CD","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","deletedIndicator":"No"},{"value":"Both","valueDescription":null,"ValueMeaning":{"publicId":"5612442","version":"1","preferredName":"Both","longName":"5612442","preferredDefinition":"One and the other; relating to or being two in conjunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"453584A6-3600-15AA-E053-F662850A2541","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"105ACA4E-F9A0-04D7-E063-731AD00A67CD","beginDate":"2024-02-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-01","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6568711","version":"1","preferredName":"Unacceptable Toxicity Category","preferredDefinition":"Failing to satisfy an established set of qualifying measures.:The finding of bodily harm due to the poisonous effects of something.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C63354:C27990:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unacceptable","conceptCode":"C63354","definition":"Failing to satisfy an established set of qualifying measures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-57A3-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97E72D-57B4-04F7-E053-F662850ACE3E","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the unacceptable toxicity related to?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"101DC31B-0461-33B6-E063-731AD00ACCA7","latestVersionIndicator":"Yes","beginDate":"2024-01-29","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-01-29","modifiedBy":"MMADDINENI","dateModified":"2024-01-29","changeDescription":null,"administrativeNotes":"1/29/2024: Created CDE(CADSR0003310)- MM","unresolvedIssues":null,"deletedIndicator":"No"}}